Journament

Keyword Connections - doxorubicin Keywords

Connection Type	Connection
Journals	ACS applied materials & interfaces Nanoscale International journal of pharmaceutics PloS one Acta biomaterialia Nanomaterials (Basel, Switzerland) Molecules (Basel, Switzerland) International journal of biological macromolecules Life sciences Bioorganic & medicinal chemistry letters international journal of nanomedicine Redox biology pakistan journal of pharmaceutical sciences acs nano nanomedicine (london, england) artificial cells, nanomedicine, and biotechnology Chemical communications (Cambridge, England) colloids and surfaces b, biointerfaces Biomacromolecules nutrition and cancer Computational biology and chemistry Theriogenology Microbial pathogenesis Applied and environmental microbiology Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine Anticancer research bioconjugate chemistry Cancers biomedical materials (bristol, england) journal of cancer research and therapeutics european journal of pharmaceutics and biopharmaceutics : official journal of arbeitsgemeinschaft fur pharmazeutische verfahrenstechnik ev drug development and industrial pharmacy journal of materials chemistry b Photodiagnosis and photodynamic therapy Pharmaceutical research The ISME journal jama oncology biomedizinische technik biomedical engineering Nature Immunology Frontiers in bioscience (Elite edition) indonesian journal of biotechnology acta physiologica (oxford, england) World journal of clinical cases Naunyn-Schmiedeberg's Archives of Pharmacology colloid and interface science communications toxicology in vitro : an international journal published in association with bibra Biotechnic & histochemistry : official publication of the Biological Stain Commission
Research Groups	No Research Group Connected
Bibliographies	[1] The aqueous extract of Gerrardanthus macrorhizus caudex enhanced doxorubicin activity in MCF-7 human breast cancer cells [2] Evaluation of drug candidature: In silico ADMET, binding interactions with CDK7 and normal cell line studies of potentially anti-breast cancer enamidines. [3] 'Stealth' corporate innovation: an emerging threat for therapeutic drug development. [4] Horizontal acquisition of a patchwork Calvin cycle by symbiotic and free-living Campylobacterota (formerly Epsilonproteobacteria). [5] Identification of 2CS-CHX operon signature of chlorhexidine tolerance among . [6] Immunization with proline rich region of pneumococcal surface protein A has no role in protection against Streptococcus pneumoniae serotype 19F. [7] Confounding by indication of the safety of de-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort. [8] Effect of pH-Responsive Charge-Conversional Polymer Coating to Cationic Reduced Graphene Oxide Nanostructures for Tumor Microenvironment-Targeted Drug Delivery Systems. [9] Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma. [10] Inverse-micelle synthesis of doxorubicin-loaded alginate/chitosan nanoparticles and assessment of breast cancer cytotoxicity. [11] Doxorubicin-induced skeletal muscle atrophy: elucidating the underlying molecular pathways. [12] Inhibition of PAR-1 Receptor Signaling by Enoxaparin Reduces Cell Proliferation and Migration in A549 Cells. [13] A precision medicine approach to defining the impact of doxorubicin on the bioenergetic-metabolite interactome in human platelets. [14] Co-delivery of doxorubicin and TRAIL plasmid by modified PAMAM dendrimer in colon cancer cells, and evaluation. [15] Light-controllable systems based on TiO-ZIF-8 composites for targeted drug release: communicating with tumour cells. [16] Ultrasensitive photoelectrochemical microRNA biosensor based on doxorubicin sensitized graphitic carbon nitride assisted by a target-activated enzyme-free DNA walker. [17] SHORT COMMUNICATION-Anticancer activity of Ziziphus mauritiana roots against human breast cancer cell line. [18] Doxorubicin combined with betulinic acid or lonidamine in RGD ligand-targeted pH-sensitive micellar system for ovarian cancer treatment. [19] Stacking as a Key Property for Creating Nanoparticles with Tunable Shape: The Case of Squalenoyl-Doxorubicin. [20] The synergistic cytotoxic effects of doxorubicin and extract on human breast cancer cell line T47-D. [21] Doxorubicin-induced toxicity to 3D-cultured rat ovarian follicles on a microfluidic chip. [22] Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report. [23] Anti-Tumor Drug-Loaded Oxygen Nanobubbles for the Degradation of HIF-1α and the Upregulation of Reactive Oxygen Species in Tumor Cells. [24] Dendrimer based theranostic nanostructures for combined chemo- and photothermal therapy of liver cancer cells in vitro. [25] Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. [26] Self-stabilized silk sericin-based nanoparticles: In vivo biocompatibility and reduced doxorubicin-induced toxicity. [27] A 2-compartment bone tumor model to investigate interactions between healthy and tumor cells. [28] Magnetic Driven Nanocarriers for pH-Responsive Doxorubicin Release in Cancer Therapy. [29] Combined Magnetoliposome Formation and Drug Loading in One Step for Efficient Alternating Current-Magnetic Field Remote-Controlled Drug Release. [30] Biocompatibility assessment of sub-5 nm silica-coated superparamagnetic iron oxide nanoparticles in human stem cells and in mice for potential application in nanomedicine. [31] Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma. [32] Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma. [33] Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells. [34] Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells. [35] Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants. [36] Facile Strategy by Hyaluronic Acid Functional Carbon Dot-Doxorubicin Nanoparticles for CD44 Targeted Drug Delivery and Enhanced Breast Cancer Therapy. [37] UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid. [38] Artemisinin attenuates doxorubicin induced cardiotoxicity and hepatotoxicity in rats. [39] Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy. [40] Doxorubicin Delivered Using Nanoparticles Camouflaged with Mesenchymal Stem Cell Membranes to Treat Colon Cancer. [41] cd20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of cd20-positive raji cells [42] alisol f 24 acetate enhances chemosensitivity and apoptosis of mcf-7/dox cells by inhibiting p-glycoprotein-mediated drug efflux [43] the ubiquitin-conjugating enzyme e2-epf is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase ii inhibition [44] hypoxia potentiates the capacity of melanoma cells to evade cisplatin and doxorubicin cytotoxicity via glycolytic shift [45] pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (imc‐3g3) to patients with advanced soft tissue sarcoma [46] taiwanese and japanese yam (dioscorea spp.) extracts attenuate doxorubicin-induced cardiotoxicity in mice [47] zno nanofluids for the improved cytotoxicity and cellular uptake of doxorubicin [48] cardioprotective efficiency study of combination of pyrimidine and 3-hydroxypyridine derivatives in experimental antitumor chemotherapy [49] nuclear localization marker of foxo3a: can it be used to predict doxorubicin response? [50] enhanced cellular uptake and pharmacokinetic characteristics of doxorubicin-valine amide prodrug [51] myeloprotective efficiency of combination of pyrimidine and 3-hydroxypyridine derivatives in experimental antineoplastic chemotherapy [52] self-assembled micelles composed of doxorubicin conjugated y-shaped peg-poly(glutamic acid)2 copolymers via hydrazone linkers [53] liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells [54] influence of doxorubicin on adhesive properties of e.coli [55] an abraded surface of doxorubicin-loaded surfactant-containing drug delivery systems effectively reduces the survival of carcinoma cells [56] a phase ib/ii study of ganetespib with doxorubicin in advanced solid tumors including relapsed-refractory small cell lung cancer [57] Transferrin-Modified Nanoliposome Codelivery Strategies for Enhancing the Cancer Therapy [58] β-Lapachone protects against doxorubicin-induced nephrotoxicity via NAD/AMPK/NF-kB in mice. [59] Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas. [60] Advanced Postsynthetic Modification of COF: Elevating Hydrophilicity for Efficient Doxorubicin Delivery. [61] Nicorandil prevents doxorubicin-induced human umbilical vein endothelial cell apoptosis. [62] Endurance Exercise Attenuates Doxorubicin-induced Cardiotoxicity. [63] Evaluation of the phytochemical composition and protective activities of methanolic extracts of and (Lipsky) Wagenitz on cardiomyocytes treated with doxorubicin. [64] Photodynamic therapy using zinc phthalocyanine in low dose of diode laser combined with doxorubicin is a synergistic combination therapy for human SK-MEL-3 melanoma cells. [65] Sugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells - Possible Role of GLUT1 Transporter. [66] Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA. [67] (C1236T) Polymorphism Affects P-Glycoprotein-Mediated Transport of Methotrexate, Doxorubicin, Actinomycin D, and Etoposide. [68] Polyelectrolyte Carboxymethyl Cellulose for Enhanced Delivery of Doxorubicin in MCF7 Breast Cancer Cells: Toxicological Evaluations in Mice Model. [69] A new thiocyanoacetamide (2-cyano-2-p-nitrophenyl-N-benzylthioamide) reduces doxorubicin-induced in vitro toxicity in Sertoli cells by decreasing apoptosis and autophagy. [70] Development and evaluation of doxorubicin self nanoemulsifying drug delivery system with Nigella Sativa oil against human hepatocellular carcinoma. [71] The aqueous extract of Gerrardanthus macrorhizus caudex enhanced doxorubicin activity in MCF-7 human breast cancer cells [72] Doxorubicin-induced senescence through NF-κB affected by the age of mouse mesenchymal stem cells. [73] Therapeutic Efficacy of Orally Delivered Doxorubicin Nanoparticles in Rat Tongue Cancer Induced by 4-Nitroquinoline 1-Oxide [74] Lipid rafts-mediated endocytosis and physiology-based cell membrane traffic models of doxorubicin liposomes [75] Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma. [76] Inverse-micelle synthesis of doxorubicin-loaded alginate/chitosan nanoparticles and assessment of breast cancer cytotoxicity. [77] Doxorubicin-induced skeletal muscle atrophy: elucidating the underlying molecular pathways. [78] Facile synthesis of multi-walled carbon nanotube via folic acid grafted nanoparticle for precise delivery of doxorubicin. [79] A precision medicine approach to defining the impact of doxorubicin on the bioenergetic-metabolite interactome in human platelets. [80] Electrical stimulation prevents doxorubicin-induced atrophy and mitochondrial loss in cultured myotubes. [81] Combination of Sodium Selenite and Doxorubicin Prodrug Ac-Phe-Lys-PABC-ADM Affects Gastric Cancer Cell Apoptosis in Xenografted Mice. [82] Synthesis and correction of albumin magnetic nanoparticles with organic compounds for absorbing and releasing doxorubicin hydrochloride [83] Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo [84] Synthesis of Isosteviol analogues as potential protective agents against Doxorubicin-induced cardiomyopathy in zebrafish embryos [85] Corrigendum to ‘Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA’ (Bioorganic & Medicinal Chemistry Letters (2019) 29(10) (1246–1255), (S0960894X19300617), (10.1016/j.bmcl.2019.01.040)) [86] Synthesis and antitumor activity of GnRH-doxorubicin conjugates [87] Process optimization for synthesis of the anticancer drug delivery vehicle P10 peptide and its interaction with doxorubicin [88] Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA [89] Controlled synthesis of biocompatible rGO@CD@Au nanocomposites for trace detection for doxorubicin by Raman imaging spectroscopy [90] A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy [91] Synthesis of Isotopically Modified Derivatives of Dopamine, Serotonin, and Doxorubicin with Boc-Pro and Boc-[<sup>2</sup>H]Pro [92] Synthesis and optimization of poly (N,N-diethylacrylamide) hydrogel and evaluation of its anticancer drug doxorubicin’s release behavior [93] Optimized synthesis, characterization and in vitro systematic evaluation of adamantane-doxorubicin prodrugs sensitive to pH in breast cancer cells [94] Synthesis and characterization of a photoresponsive doxorubicin/combretastatin A4 hybrid prodrug [95] BiFeO<inf>3</inf>-synthesis, characterization and its photocatalytic activity towards doxorubicin degradation from water [96] Retraction Note to: Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line (Journal of Nanobiotechnology (2012) 10 (46) DOI: 10.1186/1477-3155-10-46) [97] Synthesis and Functionalization of β-Glucan Particles for the Effective Delivery of Doxorubicin Molecules [98] Synthesis of poly(amidoamine)-poly(ethyleneglycol)-poly(amidoamine) and preparation of its hydrogel solution containing doxorubicin [99] The synthesis and application of nano doxorubicin-indocyanine green matrix metalloproteinase-responsive hydrogel in chemophototherapy forhead and neck squamous cell carcinoma (International Journal of Nanomedicine, 2019, 14, (623-638), 10.2147/IJN.S191069) [100] Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin (Nanotechnol Sci Appl., 2012, 5, (13-25)) [101] Modified methods of nanoparticles synthesis in ph-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line